The rising interest in GLP-1 agonists for diabetes has led to a debate about application forms : transdermal systems versus capsules. Traditionally , GLP-1 treatments were solely available in oral form, https://diegoddwf892620.blog-ezine.com/41520217/glp-1-transdermal-delivery-systems-vs-pills-what-suitable-for-you